Best Startup
At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top San Francisco based Founder operating in the Medical space. If you think a Founder is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Gaurav Agarwal
Co-Founder & CTO of 1mg
Gaurav Agarwal is CTO @ HealthKart Plus.
Follow Gaurav Agarwal:
About 1mg: 1mg is an online pharmacy network platform and generic medicine engine.
Yury Yakubchyk
Founder of Elemy
Yury Yakubchyk is the Founder of Sprout Therapy. He is also the Chief Technology Officer at Life House, where he manages the technology, growth marketing, data analytics, and digital design teams. Yury is responsible for Life House’s unique digital strategy. Previously, Yury was a Chief Technology Officer at New York-based Wing (wingalpha.com, Wing Tel, and Wing Call on the Apple App Store), a modern millennial-tailored mobile virtual network operator selling custom cellular subscription plans and mobile devices on the Sprint network. The wing is venture-backed by several prominent venture capital firms and angel investors. Prior to Wing, Yury worked in the financial services industry. Yury is a self-taught programmer and digital product designer as well as a graduate of the Johns Hopkins University, where he was a Woodrow Wilson Fellow. Yury is originally from New York City.
Follow Yury Yakubchyk:
About Cold Start Ventures, Elemy, Life House, Wing Tel, Inc.: Elemy is a B2B2C platform helping provide access to in-home pediatric care for ongoing behavioral challenges, including autism.
Stephanie Tilenius
CEO, Founder of Vida Health
Stephanie is CEO & Founder of Vida Health.
Follow Stephanie Tilenius:
About Nextdoor, Vida Health: Vida Health is a virtual care platform that provides health coaching from experienced health care providers and medical institutions.
Branko Cerny
Founder of SquareOne
Branko Cerny joined Radical as Founder, CEO in 2017
Follow Branko Cerny:
About Radical, SquareOne, SquareOne Mail, Wasabi Ventures: SquareOne works with the biggest and most established personalities and content creators in gaming.
Ian Van Every
Co-Founder & UK Managing Director of Lemonaid Health
Follow Ian Van Every:
About Lemonaid Health: Lemonaid Health is a telemedicine platform that uses technology to change the way people interact with health care.
Seth Sternberg
Co-Founder & CEO of Honor
Seth Sternberg is the Co-Founder and CEO of Honor, a non-medical home care company with a mission to enable our parents to remain in their homes as they age. Prior to Honor, Seth was the Co-Founder and CEO of Meebo, which brought instant messaging to the web and reached close to half the internet population in the United States. Meebo was acquired by Google, where Seth became a Product Director working on the Google Identity Platform, and then within GoogleX. Seth started his career with IBM’s Corporate Development group after graduating from Yale.
Follow Seth Sternberg:
About Honor, Meebo: Honor is a senior care network and technology platform that offers personalized care to improve the in-home care experience.
Chris Mansi
CEO, Co-Founder of Viz
Dr Mansi is a former Neurosurgeon and the CEO of Viz.ai an Applied AI Healthcare company.They recently received FDA clearance for the first ever AI aided triage and notification platform, opening the door to AI in acute emergency healthcare. Chris is a clinician innovator, entrepreneur and optimist focused on increasing healthcare access, building and supporting great teams and improving provider experience. Viz.ai builds clinician facing products that enable and empower doctors, allowing them to provide the best care to patients, everytime, everywhere.
Follow Chris Mansi:
About Viz: Viz is a medical imaging company that helps optimize emergency treatment using deep learning technology.
Daniel Perez
Co-Founder, CEO of Hinge Health
With a long personal history of MSK injuries including several leg surgeries, Dan has long been passionate about improving outcomes for musculoskeletal disorders. Originally from Miami, Dan pursued a PhD in the medical sciences at the University of Oxford (currently paused), founding the Oxbridge Biotech Roundtable and OneStart, a large healthcare accelerator program. As CEO, Dan brings startup technology experience and healthcare expertise to Hinge Health.
Follow Daniel Perez:
About Hinge Health: Hinge Health is a patient-centered digital clinic for treating chronic musculoskeletal conditions.
Dwight Crow
Co-Founder and CEO of Whisper
Dwight Crow is a product manager at [Facebook](https://www.crunchbase.com/organization/facebook#/entity), an online social networking service. Previously, he served as the founder of Carsabi.com. He is also the Co-Founder and CEO at Whisper.ai. Crow holds a bachelor’s degree in chemical biology and computer science from the [University of California, Berkeley](https://www.crunchbase.com/organization/university-of-california-berkeley#/entity). He is based in San Francisco, California, United States.
Follow Dwight Crow:
About Meta, Whisper: Whisper develops AI-enabled, updateable hearing aids for people with hearing loss.
Andrew Song
President and Co-Founder of Whisper
Andrew Song is the President and Co-Founder at Whisper.
Follow Andrew Song:
About Whisper: Whisper develops AI-enabled, updateable hearing aids for people with hearing loss.
Shlomo Zippel
Co-Founder of Whisper
Follow Shlomo Zippel:
About Whisper: Whisper develops AI-enabled, updateable hearing aids for people with hearing loss.
Philip Fung
Founder / CEO of Kit.com
Founder/CEO @Kit.com, Engineer #15 @Facebook
Follow Philip Fung:
About Kit.com: Kit.com is a home medical exams, delivered. Kit makes health testing simpler, easier and more reliable for your patients.
Greg Burrell
Co-Founder, VP of Clinical Product & Strategy of Carbon Health
Greg is co-founder and Director of Medicine at Carbon Health. He brings to Carbon a long-standing passion for using smart technology to overhaul the health system and improve the quality of care to patients. He has been advising and leading Bay Area healthcare startups for a number of years and most recently served as Director of Content and Clinical Solutions at CareMessage, Inc. Greg received his medical degree from the University of Chicago, completed his internal medicine residency at the University of California, San Francisco and maintains a faculty appointment as Assistant Professor of Clinical Medicine at UCSF.
Follow Greg Burrell:
About Carbon Health: Carbon Health is a tech-enabled healthcare company that delivers a virtual care experience.
Drew Perkins
Co-Founder and CEO of Mojo Vision
Follow Drew Perkins:
About Mojo Vision: Mojo Vision is developing Mojo Lens, the world’s first AR smart contact lens with a built-in display that delivers Invisible Computing
Cheng Liu
Founder, CEO of Eureka Therapeutics
Cheng Liu is the founder and CEO of Eureka Therapeutics, a California biotech company dedicated to antibody research and discovery for cancer immunotherapy. Prior to founding Eureka, Dr. Liu was a Principal Scientist in antibody drug discovery at Chiron (now Novartis), where he championed anti-CSF1 antibody program for treatment of bone metastasis to human clinical trials. He is the inventor of multiple issued US patents in drug discovery. In 2007, he was awarded Special US Congressional Recognition for his contributions to improving human health. Dr. Liu received his B.S. in Cell Biology and Genetics from Beijing University and a Ph.D. in Molecular Cell Biology from the University of California, Berkeley.
Follow Cheng Liu:
About Eureka Therapeutics: Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
Sami Inkinen
CEO & Founder of Virta Health
Sami Inkinen is the Chief Executive Officer and Co-Founder of Virta Health, a specialty medical clinic that reverses type 2 diabetes safely and sustainably, without the risks, costs, or side effects of medications or surgery. Previously, Mr. Inkinen was the co-founder of the leading online real estate marketplace Trulia, serving as its COO and president and board member until its IPO and eventual sale to Zillow Group. He also worked on Microsoft’s strategy team for MS Office, and as a consultant for McKinsey & Company within the software, telecommunications, and government sectors. A physicist by training, Mr. Inkinen started his career as a radiochemist at a nuclear power plant and holds a Master of Science in engineering physics from the Helsinki University of Technology. He also earned a Master of Business Administration from Stanford University. He thinks his greatest luxury today is a small vegetable garden at his San Francisco Bay area home.
Follow Sami Inkinen:
About Virta Health: Virta delivers a clinically-proven treatment to reverse type 2 diabetes and other chronic metabolic diseases.
Oguzhan Atay
Co-Founder of BillionToOne
Oguzhan is responsible for implementing BillionToOne’s vision and for all day-to-day management decisions. During his PhD at Stanford, he has combined machine learning and genetics to solve problems in cell biology. His PhD research has been featured as Cover Article in Cell Systems, and his work has been published in high-impact peer-reviewed journals, including Cell and Journal of Cell Biology.
Follow Oguzhan Atay:
About BillionToOne: BillionToOne is a precision diagnostics company that makes molecular diagnostics accurate, efficient, and accessible for all.
Fabien Beckers
Founder & CEO of Arterys
Fabien Beckers is the CEO and co-founder of Arterys, a cloud/deep learning startup that is disrupting the medical imaging space and building image-based precision medicine tools. Fabien has led the growth of the company from four co-founders to a team of 34 today. Under his leadership, the company has become a pioneer in cloud-based medical imaging software, offering the first FDA-cleared end-to-end cloud infrastructure for medical imaging. They key advantages of the platform being automatic aggregation of real-world data and ability to scale and distribute the processing of increasingly large, complex datasets. Fabien’s vision for the company is to accelerate data-driven medicine by building precision medicine tools based on the consistent quantification of medical image features in combination with molecular, genomics and patient history data. Fabien holds a PhD in Quantum Physics from the University of Cambridge and a masters of business from Stanford University.
Follow Fabien Beckers:
About Arterys: Arterys is a medical imaging platform to deliver clinical AI products over the internet.
Christine Lemke
Co-Founder & President of Evidation Health
As Chief Product Officer, Christine leads product management and development at Evidation Health. Previously, Christine co-founded and led The Activity Exchange, an insight and personalization platform that helps healthcare companies deliver the right digital interventions and incentives to consumers to help them achieve sustainable behavior change. Prior to her work in healthcare, Christine was the co-founder and Chief Operating Officer of Sense Networks, developers of the first machine learning platform for mobile phone activity data (exited to YP.com). She has also held roles at 3iGroup (Paris), Microsoft XBOX and co-founded Chicago-based Channel IQ, a product analytics platform. Christine has a BA from the University of Washington and an MBA from HEC Paris.
Follow Christine Lemke:
About Evidation Health, Evidation Health: We enable and empower everyone to participate in better health outcomes.
Mikki Nasch
Head of Business Development & Co-Founder of Evidation Health
Mikki Nasch is responsible for business development at Evidation Health. Most recently, Mikki cofounded and led business activities at The Activity Exchange. Previously, Mikki was on the founding team of Sense Networks (exited to YP.com) and served as EVP of Business Development. Mikki has been the Vice President of Market Management at Fair Isaac, Inc. (NYSE: FIC), held leadership positions in the incubation phase of numerous startups, and led development of products, sales strategies, business models and corporate vision, leading early-stage software venture capital funds. She was a founding member of BackWeb Technologies (NASD: BWEB), and began her career as a network engineer for the US and European governments.
Follow Mikki Nasch:
About Evidation Health: We enable and empower everyone to participate in better health outcomes.
Uday Kumar
Founder, President, CEO, and Board Member of Element Science
Co-Founder & Board Member at Sympara Medical – Dr. Uday N. Kumar, a cardiologist and cardiac electrophysiologist by training.
Follow Uday Kumar:
About Element Science, Stanford University, Sympara Medical: Element Science is a medical device and digital health start-up that develops lifesaving wearable solutions.
Naama Stauber Breckler
CEO & Co-Founder of Better Health
Naama is a healthcare entrepreneur and the CEO and Co-founder of Better Health. She holds an MBA from Stanford GSB and is an experienced software engineer and product manager. She is dedicated to creating human centric healthcare solutions to improve our healthcare system. Naama previously co-founded CompactCath, MocaCare and Avails Medical.
Follow Naama Stauber Breckler:
About Avails Medical, Better Health, MOCACARE: Better Health offers an end-to-end care solution, bundling peer-support, coaching, education and home delivery of medical supplies
Adam Breckler
Co-Founder and Head of Product of Better Health
Adam Breckler is the Co-Founder and Head of Product at Better Health.
Follow Adam Breckler:
About Better Health: Better Health offers an end-to-end care solution, bundling peer-support, coaching, education and home delivery of medical supplies
Lucia Huang
Co-Founder and CEO of Osmind
Lucia is CEO and co-founder of Osmind. We’re building a care platform for treatment-resistant mental health to accelerate drug development & precision medicine. She was previously Director of Operations & Finance and employee #10 at Verge Genomics (YC S15), an early stage AI-driven biotech startup focused on brain diseases. She began her career in healthcare in investment banking at Evercore and then as a investor at Warburg Pincus focused on growth-stage healthcare IT companies. She will complete her MBA at Stanford Graduate Business School of Business in June 2020 and studied Chemistry at Yale.
Follow Lucia Huang:
About Osmind: We build software and accelerate research for the future of mental health.
Andrew Lockhart
Co-Founder, Board Member & Chief Executive Officer of Fathom
Follow Andrew Lockhart:
About Fathom: Fathom develops a coding automation platform designed to expedite medical coding practice.
Kristina Cahojova
Founder & CEO of kegg
Kristina Cahojova is the Founder and CEO of Kegg.
Follow Kristina Cahojova:
About kegg: Kegg is a two-in-one device that combines fertility tracking with pelvic floor exercising.
Daniel Burnett
Founder and Chairman of Bone Health Technologies
Dr. Burnett has a long history of biomedical device design and testing. After graduating from University of Pennsylvania’s school of Bioengineering, Dr. Burnett spent a year at the Food and Drug Administration both testing devices and writing congressional reports on the current state-of-the- art devices. Following receipt of his MD and MBA degrees from Duke University, Dr. Burnett completed his one-year internship at the Mayo Clinic in Jacksonville, FL and is currently a licensed physician in the state of California. After working for two years as a General Partner with MedVenture Associates, a medical device venture capital firm in Emeryville, CA, Dr. Burnett left the firm in 2006 and committed himself to TheraNova and its subsidiaries.
Follow Daniel Burnett:
About Ananya Health, Anathem Ventures, Bone Health Technologies, Channel Medsystems, Consano, Gravitas Medical, Perikinetics, Potrero Medical, Respirix, TheraNova LLC., University of California, San Francisco: Bone Health Technologies is developing a new standard of care for treating both osteoporosis and osteopenia, the precursor to osteoporosis.
Michael Geer
Co-Founder & CSO of Humanity
Michael Geer (MG) was founding team at Badoo (grew to largest dating site in the world and spawned the Social Discovery sector). He then ran operations at AnchorFree which became the largest consumer VPN in the world with over 700 million users. He now has cofounded Humanity with Peter Ward to extend the healthspan (healthy fully functional years of life) of every person on earth.
Follow Michael Geer:
About Humanity, Humanity: Humanity is a healthcare company that aims to extend the healthspan of humanity.
Ben Jacobs
Co-Founder of Modern Animal
Ben Jacobs is the Co-Founder of Modern Animal.He co-founded Whistle as an Entrepreneur in Residence at venture capital firm DCM Ventures. Prior to DCM, he was at Bain where he worked with clients in the pet and technology industries. Ben holds undergraduate and graduate degrees from Yale University with a focus on China.
Follow Ben Jacobs:
About Modern Animal: Modern Animal is an innovative veterinary platform building a new kind of veterinary experience for animals and humans.
Steven Eidelman
Co-Founder and CEO of Modern Animal
Steven Eidelman is the Co-Founder and CEO of Modern Animal. He co-founded Whistle following his time at Spectrum Equity, where he focused on investments in consumer Internet. Previously he spent time driving online strategy for Warner Music Group and working at Bain for a number of technology, healthcare, and private equity clients. Steven graduated from the University of Pennsylvania with a BA in Political Science.
Follow Steven Eidelman:
About Modern Animal: Modern Animal is an innovative veterinary platform building a new kind of veterinary experience for animals and humans.
Noga Leviner
Co-Founder & CEO of PicnicHealth
Noga was inspired to create Picnic after being diagnosed with an autoimmune disease and struggling to keep track of her own health data. She had previously co-founded Lumni USA, where she raised and deployed the first US investment fund to help underserved students access low-risk, equity-style student loan products. She has been a regular speaker and consultant on financial innovation for the underbanked and, more recently, an advocate for patient data access in the healthcare system. Noga has a BA from Stanford where she studied Human Biology and Economics. She can regularly be found spacing out while trying to meditate.
Follow Noga Leviner:
About PicnicHealth: PicnicHealth helps patients easily access their medical records and gives them the opportunity to contribute data to medical research.
Troy Astorino
Co-Founder & CTO of PicnicHealth
Follow Troy Astorino:
About PicnicHealth: PicnicHealth helps patients easily access their medical records and gives them the opportunity to contribute data to medical research.
Rakesh Mathur
Co-Founder & CEO of Whiterabbit.ai
Rakesh is a co-founder of Webaroo. He has been a founder of three technology start up companies in the past 10 years and also an early stage investor in several other companies. He was a founder and CEO of Junglee, whose virtual database technology led to the creation of comparison shopping on the Internet. Junglee was acquired by Amazon.com in 1998. He founded Armedia, which was one of the first companies with chip designs for the video component of the DVD standard. Armedia was acquired by Broadcom in 1999. He also founded PurpleYogi, now Stratify which provides enterprise solutions to the management of unstructured data. Rakesh is a board member of Geodesic, a BSE listed company whose Mundu Instant Messenger is used by millions of people. Rakesh was recognized as a member of the 1998 Upside 100, the 2001 India Today Global 100 and Junglee technology was given the Computerworld – Smithsonian award as one of the top five technologies of 1998. Rakesh received his MS from the University of Texas at Arlington and his B.Tech from IIT Bombay.
Follow Rakesh Mathur:
About GupShup, Percipient.ai, Terralogic, WhiteRabbit, Whiterabbit.ai: Whiterabbit.ai develops software using artificial intelligence to detect cancer at the earliest stages.
Kyle Robertson
Founder and CEO of Cerebral
Kyle Robertson is the Co-Founder and Chief Executive Officer of Cerebral.
Follow Kyle Robertson:
About Cerebral: Cerebral is a mental health telemedicine company that offers online care and medication management for anxiety, depression, ADHD and more.
Talha Sattar
CEO & Founder of NimbleRx
Follow Talha Sattar:
About NimbleRx: Nimble provides a pharmacy experience centered around the patient’s needs to provide a more streamlined workflow.
Anne DeGheest
Founder & Managing director of HealthTech Capital
Anne DeGheest is a mentor capitalist specializing in investing and mentoring early-stage start-ups in healthcare. She founded MedStars Ventures Partners and HealthTech Capital, a new ecosystem between private angel investors, venture capitalists and industry players to fund and mentor new “HealthTech” companies that decrease healthcare cost by leveraging computer and mobility technology. The life science companies for which she has been a founder or an early advisor have generated over $6 billion in market capitalization including Pyxis (now part of CareFusion), Aspect Medical (acquired by Covidien), VISX (acquired by AMO), Thermage (merged into Solta Medical), VISICU(acquired by Philips), Masimo (Nasdaq: MASI), Nellcor (a division of Covidien), MedPool and OmniCell (Nasdaq: OMCL).She has an MBA from Harvard and a Master in Business Engineering from University of Brussels.
Follow Anne DeGheest:
About HealthTech Capital, Medstars: HealthTech Capital is a group of private investors dedicated to funding and mentoring new HealthTech start ups
Fabian Gerlinghaus
Co-Founder & CEO of Cellares
Fabian Gerlinghaus is the CEO and Co-Founder of Cellares.
Follow Fabian Gerlinghaus:
About Cellares: Cellares is a life sciences technology company that develops the Cell Shuttle to automate cell therapy manufacturing.
Jason Bellet
Co-Founder, Chief Strategy Officer, Board Member of Eko Health
Follow Jason Bellet:
About Eko Health: Eko develops AI-powered digital tools to detect and monitor heart and lung disease
Wenbin Jiang
Co-Founder and CEO of Cytek Biosciences
Wenbin Jiang is a co-founder of Cytek Biosciences, Inc. and a seasoned entrepreneur and inventor. E2O communications was the first company he cofounded in late 1990s, which was acquired by JDS Uniphase in 2004. He is an inventor of more than 90 US patents and an author of 4 book chapters and more than 50 peer reviewed technical papers.
Follow Wenbin Jiang:
About Cytek Biosciences: Cytek Biosciences is a manufacturer and supplier of flow cytometry products and services.
Ming Yan
Co-Founder and CTO of Cytek Biosciences
Ming Yan is a co-founder of Cytek Biosciences, Inc. with over 20 years of R&D experience in leadership and innovation. Prior to Cytek, Ming Yan held research and development positions at AT&T Bell Laboratories, Lawrence Livermore National Labs and BD Biosciences. He is one of the thought-leaders in flow cytometry instrumentation and standardization. Ming Yan has published several research papers relating to laser spectroscopy and cell analysis in top peer-reviewed journals. He has over a dozen patents and patent pending applications for his innovations.
Follow Ming Yan:
About Cytek Biosciences: Cytek Biosciences is a manufacturer and supplier of flow cytometry products and services.
James H. Bullard
Co-Founder and CTO of Pendulum Therapeutics
James Bullard is a Computational Biologist and Biostatistician with extensive experience in analyzing complex genomic systems. Prior to co-founding Whole Biome, Jim served as a Senior Staff Scientist at Pacific Biosciences. Jim, completed his Ph.D. in Biostatistics with a focus in Computational and Genomic Biology at the University of California, Berkeley and his B.A. in Computing and Information Systems at Northwestern University.
Follow James H. Bullard:
About Pendulum Therapeutics: Pendulum Therapeutics is a biotechnology company improving health through products targeting the microbiome.
Colleen Cutcliffe
Co-Founder and CEO of Pendulum Therapeutics
Colleen Cutcliffe is the Co-Founder and CEO of Pendulum Therapeutics.
Follow Colleen Cutcliffe:
About American Diabetes Association, California Life Sciences Association, Pendulum Therapeutics: Pendulum Therapeutics is a biotechnology company improving health through products targeting the microbiome.
John S. Eid
Co-Founder and CSO of Pendulum Therapeutics
John Eid is a Biophysicist who has led fundamental technology development for over a decade. His research areas include advanced microscopy, single molecule detection and analyses, automated data acquisition system development, biophysical system modeling, genome sequencing applications and bioinformatics. Prior to co-founding Whole Biome, John served as a Principle Scientist at Pacific Biosciences. He joined the company shortly after it was founded and created, developed and applied its core sequencing technology from its incipient stages through commercialization. John completed his postdoctoral research at the Roland Institute at Harvard University, his Ph.D. in Biophysics and Computation Biology at the University of Illinois, Urbana Champaign, and his B.S. in Applied and Engineering Physics from Cornell University.
Follow John S. Eid:
About Pendulum Therapeutics: Pendulum Therapeutics is a biotechnology company improving health through products targeting the microbiome.
Nancy Yu
Co-Founder & CEO of AllStripes
Nancy previously led Corporate Development at 23andMe, the largest consumer genetics company. She worked on 23andMe’s next generation sequencing platform, drug discovery strategy, and business development programs. Before that, she worked on Wall Street as a biopharma investment banker. Nancy began her career doing genetics research at the University of Pennsylvania. She’s passionate about bridging the gap between patients and industry to make drug R&D cheaper, faster, and better.
Follow Nancy Yu:
About AllStripes: AllStripes is a healthcare technology company that accelerates drug development and research for the treatment of rare diseases.
Arad Rostampour
CEO and Founder of Zenamins
Arad Rostampour is Founder at Zenamins.
Follow Arad Rostampour:
About Zenamins: Zenamins is a subscription service that home delivers a monthly box of preferred vitamins to its subscribers.
Richard Lin
CEO & Co Founder of Ombre
Follow Richard Lin:
About Ombre: Ombre is a provider of a microbiome testing kit designed to incorporate personalized probiotics and microbiome testing.
Sy Fahimi
Co-Founder and CEO of DocSpera
Sy Fahimi serves as a Member of the Executive Team and Operating Partner at Symphony Technology Group. He was Executive-in-Residence at the firm. Fahimi leads the strategy and innovation charter across several portfolio companies. Until 2012, Fahimi was In Charge of Yahoo’s Monetization and Emerging Market products. Prior to 2012, he held various Vice President positions including Head of Yahoo’s Advertising Products globally, which also encompassed mobile, video, and social monetization. He ran Yahoo Small Business and Emerging Markets Products for the company. He served as the Chief Executive Officer of Adteractive, Inc. He joined Adteractive in October 2005. He served as the Managing Director of West Coast Office of SSA & Company, LLC since January 26, 2009. Fahimi has diverse experience with privately held, venture-backed and large public technology companies, along with SSA & Company’s long-standing consulting credibility and process improvement thought leadership. Prior to joining Adteractive, Fahimi spent most of his career in senior executive positions at Fortune 500 companies including Intuit, Sun Microsystems, and General Electric, where he held several executive positions including Operations, Marketing, Sales Ops, Risk Management, Quality, Finance, and Org./Process Excellence. During his tenure at GE, he became a certified Master Black Belt in the Six Sigma methodology, and served in two Vice President Positions. Fahimi began his career at GE, where he provided audit and consulting services to a wide variety of business units around the globe. In 2000, he joined Sun Microsystems as a Director of Six Sigma Quality and Customer Advocacy. After becoming a Senior Director of Global Sales Operations at Sun, he joined Intuit Corporation in a number of operating, customer advocacy, and process/organizational leadership roles. As an active entrepreneur over the last ten years, he has served as an Advisor, Investor or Board Member to several technology enabled start-ups such as Mint (Intuit), Empire Avenue, Sales Portal, Progresso Financiero, Blackfire Research Corporation, as well as being the Co-Founder of Compliant Innovations. Fahimi served as an Advisor, providing consulting services and early stage investment guidance to select start-up companies in Silicon Valley. He has been a Director of Empire Avenue Inc. since December 10, 2013. He has experience in international software, e-commerce, and digital media. Fahimi earned an M.B.A. from the Anderson School of Business at UCLA and a Bachelors degrees from University of California at Berkeley in and EconomicsEngineering .
Follow Sy Fahimi:
About DocSpera, Symphony Technology Group: DocSpera provides web and mobile solutions addressing surgical care coordination challenges facing health systems & devices
Zak Holdsworth
Co-Founder & CEO of Hint Health
Zak Holdsworth is the Co-founder & CEO at Hint Health.
Follow Zak Holdsworth:
About Hint Health: Hint Health fixes healthcare system by fundamentally restructuring the way that care is delivered.
Amir Belson
Founder and CTO of Emboline
Amir Belson Prior to conceiving of and starting ZipLine Medical, Amir Belson, M.D., was the founder of Neoguide Systems, a company that developed platform technology for minimally invasive surgical procedures that was later acquired by Intuitive Surgical in 2009. Belson is also the founder of Vascular Pathways, a company that developed an FDA cleared vascular intervention technology that has been chosen as one of the 10 best inventions of 2009 by Popular Science magazine, Thermocure, a minimally invasive therapeutic hypothermia technology company, Radguard Medical, a radiation protection medical device company and VasoStitch, which develops large vessel access and closure technology. Belson graduated cum laude from the school of medicine of the Technion, Israel Institute of Technology, in Haifa, Israel. He did his pediatric residency at Dana Children’s Hospital in Tel Aviv and his pediatric nephrology fellowship at Lucile Packard Children’s Hospital at Stanford. He also served several years as a flight surgeon in Israel’s air force rescue unit before moving to the US for a three year Pediatric Nephrology fellowship at Stanford University Medical Center. Belson also spent one year as a research fellow with the Biomedical Technology Innovation Program at Stanford.
Follow Amir Belson:
About Emboline, Modular Surgical, Qool Therapeutics, Radiaction, Zipline Medical: Emboline is a medical device company with a game-changing device for total embolic protection during percutaneous heart valve repair.
Kelsey Mellard
CEO & Co-Founder of Sitka
Kelsey Mellard is the CEO and Founder of Sitka, a first-of-its-kind medical vConsults platform and specialty provider network. She launched Sitka in 2018 to help improve access to and delivery of specialty care across the nation. Prior to founding Sitka, Kelsey led Health System Integration at Honor, a comprehensive technology-backed home care company. Before joining the Honor, Kelsey led the development of the Post-Acute Care Center for Research (PACCR), which she served as its Executive Director. Kelsey also served in VP roles at naviHealth, UnitedHealth Group, the Center for Medicare and Medicaid Innovation (CMMI), and held positions at Advisory Board Company, Children’s Mercy Hospitals and Clinics, and Kaiser Family Foundation. Kelsey holds a Bachelor’s of Science Degree in Community Health from Winona State University and a Master’s degree in Public Administration from the University of Kansas. She also currently serves as an adjunct faculty member at Winona State University in the College of Nursing and Health Services.
Follow Kelsey Mellard:
About Sitka, Winona State University: Sitka is a customizable video software platform that connects primary care providers to the virtual specialty provider network.
Shadi Saberi
Co-Founder & Chief Technology Officer of iSono Health
Shadi loves solving challenging problems in healthcare that impact lives of so many, especially women. She believes consumer engagement in their own health through accessible and personalized medical technology is key to prevention and early detection. She has over 10 years of experience designing consumer electronic. Before co-founding iSonoHealth, she worked at broadcom and Intel. She has a Ph.D. in Electrical and Computer Engineering from Carnegie Mellon.
Follow Shadi Saberi:
About iSono Health: iSono Health develops an AI platform for accessible and personalized breast health monitoring
Maryam Ziaei
Co-Founder & Chief Executive Officer of iSono Health
Maryam Ziaei is the Co-Founder & CEO at iSono Health.
Follow Maryam Ziaei:
About iSono Health: iSono Health develops an AI platform for accessible and personalized breast health monitoring
Shan X Wang
Co-Founder of Flux Bioscience
Follow Shan X Wang:
About Flux Bioscience: Flux Biosciences is a company spun out of Stanford University, where the technology used to read and write computer hard drives .
Eric Schadt
CEO & Founder of Sema4
Eric Schadt is Chief Scientific Officer of Pacific Biosciences and Director of the Institute for Genomics and Multiscale Biology and Chair of the Department of Genetics and Genomics Sciences at The Mount Sinai Medical Center. He oversees the scientific strategy for Pacific Biosciences, including creating the vision for next-generation applications of the company’s technology, contributing to the evolution of Pacific Biosciences’ transformative sequencing technology, and playing a key role in the company’s strategic relationships. At Mount Sinai, Eric is creating a world-class data analytic center where researchers can query and learn from data using cutting-edge technologies like next generation sequencing to create disease models and ultimately help develop and improve the diagnosis and treatment of patients. He is also a founding member of Sage Bionetworks, an open-access genomics initiative designed to build and support databases and an accessible platform for creating innovative dynamic disease models. Eric Schadt joined Pacific Biosciences in May 2009 from Rosetta Inpharmatics, a subsidiary of Merck & Co., Inc. in Seattle, where he was Executive Scientific Director of Genetics. Eric Schadt’s work at Rosetta involved the generation and integration of very large-scale sequence variation, molecular profiling, and clinical data in disease populations to construct the molecular networks that define disease states and link molecular biology to physiology in ways that can impact clinical medicine. Eric Schadt has contributed to a number of discoveries relating to the genetic basis of common human diseases such as diabetes and obesity, which have been widely published in leading scientific journals. His research has provided novel insights into what is needed to master diverse, large-scale data collected on normal and disease populations in order to elucidate the complexity of disease and make more informed decisions in the drug discovery arena. Prior to joining Rosetta, Eric Schadt was a senior research scientist at Roche Bioscience. He received his BA in applied mathematics and computer science from California Polytechnic State University, his MA in pure mathematics from UCLA, and his Ph.D. in bio-mathematics from UCLA.
Follow Eric Schadt:
About Icahn School of Medicine at Mount Sinai, Icahn School of Medicine at Mount Sinai, Sage Bionetworks, Sema4: Sema4 uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.
Anand Parikh
Founder & CEO of Faeth Therapeutics
Follow Anand Parikh:
About Faeth Therapeutics, Virta Health: Faeth Therapeutics is a data-driven company that focuses on using metabolism to rethink the science of cancer.
Andrew Pedtke
Co-Founder and CEO of LIM Innovations
Andrew Pedtke, MD is the CEO and Co-founder of LIM Innovations. As a practicing orthopedic surgeon and visiting Assistant Professor at the University of California, Davis. Dr. Pedtke brings a critical vision to LIM Innovations and the industry as a whole through his background in the clinical utility of medical devices, outcomes based decision-making, cost-effective care and global health policy.
Follow Andrew Pedtke:
About 413 Ventures, LIM Innovations, The Explorers Club, University of California Davis: At LIM Innovations we empower amputees by creating custom, innovative, sustainable and accessible prosthetic sockets.
Charles A. Taylor
Founder and Chief Technology Officer of HeartFlow
Charles Taylor is a co-founder, Chief Technology Officer (CTO), and member of the Board of Directors of HeartFlow Inc. Previously, he was an Associate Professor in the Department of Bioengineering and Surgery at Stanford University with courtesy faculty appointments in the Departments of Mechanical Engineering and Radiology. He is internationally recognized for the development of computer modeling and imaging techniques for cardiovascular disease research, device design and treatment planning. He received his B.S. degree in Mechanical Engineering, M.S. degree in Mechanical Engineering and M.S. degree in Mathematics from Rensselaer Polytechnic Institute and a Ph.D. in Mechanical Engineering from Stanford University.
Follow Charles A. Taylor:
About HeartFlow: HeartFlow is a medical technology company that provides new methods of diagnosis and treatment of cardiovascular disease.
Juan Jaen
President & Co-Founder of Arcus Biosciences
Juan has been engaged in all aspects of drug discovery and development for more than 30 years. In 2015, he co-founded Arcus Biosciences together with Terry Rosen. Prior to that, he was co-founder and President/Head of R&D at Flexus Biosciences, until its acquisition by Bristol-Myers Squibb for $1.25 billion. Previously, he was Chief Scientific Officer and Senior Vice President of Drug Discovery at ChemoCentryx. During his tenure there of just under 7 years, Juan led the discovery and progression into the clinic of 8 novel drug candidates in the immunology space. At ChemoCentryx, Juan led the discovery efforts for the multi-year collaboration with GSK, which generated over $100M in non-dilutive milestones and fees. From 1996 to 2006, Juan held various scientific management positions at Tularik (responsible for about 100 scientists in Medicinal and Computational Chemistry, as well as Structural Biology) and then Amgen Inc. (after its acquisition of Tularik in 2004), most recently as Vice President of Chemistry. From 1983 to 1996, Juan held various scientific leadership positions at Parke-Davis/Warner-Lambert. Juan holds a Visiting Scholar appointment (ChEM-H) at Stanford University and is a member of the Scientific Advisory Board at Cleave Biosciences. Juan obtained a B.S. degree in Chemistry from Universidad Complutense in Madrid (Spain) and a Ph.D. degree in Organic Chemistry from the University of Michigan. He has co-authored over 100 scientific papers and is an inventor on 50 issued U.S. patents. Juan has been responsible for the advancement of over 20 novel molecules into clinical development for diseases including cancer, Alzheimer’s, Crohn’s, RA, diabetes and diabetic nephropathy, psoriasis, asthma, and vasculitis, among others.
Follow Juan Jaen:
About Arcus Biosciences: Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.
Jeremy Dabor
CPO & Co-Founder of Sensassure
Follow Jeremy Dabor:
About Sensassure: An impact-driven company creating innovative technologies to improve senior care.
Kristian Ranta
CEO, Founder of Meru Health
Kristian Ranta is a Co-Founder & Chief Executive Officer at Meru Health.
Follow Kristian Ranta:
About Meru Health: Meru Health is an online mental healthcare company that teaches people the skills needed to create long-lasting healthy lifestyle habits.
Jin-Long Chen
Founder and Chief Scientific Officer of NGM Biopharmaceuticals
Jin-Long Chen was most recently Vice President of Research at Amgen and head of the Metabolic Disorders therapeutic area. In this role he assumed global responsibility for the company’s research efforts in the areas of metabolism, bone, mineral balance, and muscle. He successfully guided programs from the earliest stages of drug discovery through advanced clinical trials and made key contributions to business development and product commercialization. Jin-Long Chen further bolstered Amgen’s drug portfolio by successfully in-licensing promising clinical candidates and out-licensing suitable clinical-stage molecules. Previously, Jin-Long Chen served as Vice President of Biology at Tularik and was responsible for drug discovery research in oncology, inflammation and metabolic disease. He personally initiated and directed Tularik’s orphan receptor programs, advancing a number of candidates, targeting selected GPCRs and nuclear hormone receptors, to the clinic. Several of these compounds remain in clinical development, including T131, a novel modulator of PPARy activity for the treatment of type 2 diabetes. While at Tularik, Jin-Long Chen was also active in business development, successfully establishing and managing pharma partnerships in support of the company’s metabolic and genomic research programs.
Follow Jin-Long Chen:
About NGM Biopharmaceuticals: NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Shannon Goggin
CEO & Co-Founder of Noyo
Shannon Goggin is the CEO and Co-Founder of Noyo.
Follow Shannon Goggin:
About Noyo: Modern infrastructure for health insurance
Jordan Shlain
Founder & CEO of Private Medical
Jordan is a practicing physician who is building new models of healthcare delivery. On his 15 year journey he is actively deconstructing the status quo and rebuilding a model that honors the existential humanistic qualities of people while infusing the best technologies to enhance the patient experience, the physician experience and ultimately the patient outcome. When not practicing medicine, you can find him reading books on quantum physics, behavioral economics, statistics, art history and anthropology. Dr. Jordan Shlain is a nationally recognized physician for his innovative approach to the delivery of healthcare. In addition to being a full time doctor and founder of Healthloop, he has been appointed commissioner by the Mayor to the SF Health Service Systems Board and sits on the board of the bi-partisian Washington, DC policy think tank, Hope Street Group. He has been named one of the top 100 health care innovators by HealthSpottr. In addition to being a frequent speaker at various conferences; Health 2.0, RockHealth, Economist Big Ideas, Futuremed and UC Berkeley’s Pre-Med 101, he consults with the investor community as a due diligence expert.
Follow Jordan Shlain:
About American Medical Association, Bright HealthCare, Digital Wellness Lab, Eat Real, HealthLoop, Private Medical, TinctureHealth: A Medical Family Office
Peter Fitzgerald
Co-Founder and Managing Partner of Triventures
Peter Fitzgerald is the Director of the Center for Cardiovascular Technology and Director of the Cardiovascular Core Analysis Laboratory (CCAL) at Stanford University Medical School. He is an Interventional Cardiologist and has a PhD in Engineering. He is Professor in both the Departments of Medicine and Engineering at Stanford. Presently, Peter Fitzgerald’s laboratory includes 17 postdoctoral fellows and graduate engineering students focusing on state-of-the-art technologies in Cardiovascular Medicine. He has led or participated in over 150 clinical trials, published over 450 manuscripts/chapters, and lectures worldwide. He has trained over 150 post-docs in Engineering and Medicine in the past decade. In addition, he heads the Stanford/Asia MedTech innovation program Peter has been principle/founder of eighteen medical device companies in the San Francisco Bay Area. He has transitioned twelve of these start-ups to large medical device companies.
Follow Peter Fitzgerald:
About Triventures: Triventures is a venture capital fund focused on investing in data driven healthcare solutions and disruptive medical devices
James Spudich
Founder of MyoKardia
James Spudich, Ph.D., serves as the Douglass M. and Nola Leishman Professor of Cardiovascular Disease in the Department of Biochemistry at Stanford University. His laboratory studies how enzymes use specific structural elements to carry out their exquisite roles. Specifically, his research has focused on the myosin family of enzymes. Over the last 35 years, Dr. Spudich and scientists in his lab have used an interdisciplinary and multifaceted approach to elucidate the molecular basis of energy transduction by the myosin family of molecular motors. Dr. Spudich also serves as a visiting faculty member at the National Center for Biological Sciences of the Tata Institute of Fundamental Research in Bangalore, India. Dr. Spudich is a co-founder and former director of Cytokinetics and the Stanford University Bio-X program. He currently serves as the chair of the International Affairs Committee for the American Society for Cell Biology, and has previously served as president of the organization. Dr. Spudich has been recognized with numerous honors for his achievements in the field, including the American Heart Association Basic Research Prize and the 2012 Lasker Basic Medical Research Award. He is an elected member of the National Academy of Sciences, American Academy of Arts and Sciences and the American Association for the Advancement of Science. He has authored more than 190 peer-reviewed publications. Dr. Spudich holds a B.S. in chemistry from the University of Illinois at Champaign-Urbana and Ph.D. in biochemistry from Stanford University. He completed his postdoctoral work in genetics and structural biology at Stanford University and the MRC Laboratory of Molecular Biology in Cambridge, England.
Follow James Spudich:
About MyoKardia: MyoKardia is a clinical-stage biopharmaceutical company that develops targeted therapies for the treatment of rare cardiovascular diseases.
Christine Seidman
Founder of MyoKardia
Christine (Kricket) Seidman, M.D., is a Professor of Genetics and the Thomas W. Smith Professor of Medicine at Harvard Medical School and Brigham and Women’s Hospital. She is also an investigator of the Howard Hughes Medical Institute. She joined the staff at Brigham and Women’s Hospital in 1987 and is currently the director of the Cardiovascular Genetics Center. Along with her husband Jonathan Seidman, Ph.D., Dr. Seidman has elucidated multiple genetic causes of human disorders affecting the heart and vasculature. The Seidmans’ discoveries include the identification and demonstration of genetic mutations causing hypertrophic cardiomyopathy and dilated cardiomyopathy, as well as the first genetic cause of congenital heart malformations. In addition to recognition received jointly with her husband, Dr. Seidman’s recent honors include Distinguished Scientist, American Heart Association; Distinguished Alumni Achievement Award, The George Washington University; The 21st Annual Glorney-Raisbeck Award; and the Jay and Jean Schottenstein Prize in Cardiovascular Science. She is a member of the Association of University Cardiologists and an elected member to the National Academy of Sciences. Dr. Seidman holds an undergraduate degree from Harvard College and an M.D. from George Washington University School of Medicine. Dr. Seidman served as an intern and resident in internal medicine at John Hopkins Hospital and received subspecialty training in cardiology at the Massachusetts General Hospital.
Follow Christine Seidman:
About MyoKardia: MyoKardia is a clinical-stage biopharmaceutical company that develops targeted therapies for the treatment of rare cardiovascular diseases.
Jonathan Seidman
Founder of MyoKardia
Professor at Harvard Medical School.
Follow Jonathan Seidman:
About Harvard Medical School, MyoKardia: MyoKardia is a clinical-stage biopharmaceutical company that develops targeted therapies for the treatment of rare cardiovascular diseases.
Kinkead Reiling
Founder and CEO of Bonneville Labs
Follow Kinkead Reiling:
About Bonneville Labs: Bonneville Labs offers lab equipment setup, training, lab operational, office amenities and autoclaving services to its clients.
Sara Naseri
Co-Founder and CEO of Qvin
Sara Naseri is the Co-Founder and CEO at Qvin.
Follow Sara Naseri:
About Qvin, Stanford University School of Medicine: Qvin is a developer of a smart sanitary pad for women to proactively track their health.
Soren Therkelsen
Co-Founder and COO of Qvin
Soren Therkelsen is the Co-founder and COO at Qvin.
Follow Soren Therkelsen:
About Qvin, Sandbox, SCALEit: Qvin is a developer of a smart sanitary pad for women to proactively track their health.
Tyler Hayes
Co-Founder and CEO of Atom Limbs
Tyler Hayes is the Co-Founder and CEO at Atom Limbs.
Follow Tyler Hayes:
About Atom Limbs: Atom builds mind-controlled artificial limbs, to enable a better human body.
Carol Sands
Founder and the Managing Member of The Angels’ Forum
Carol Sands is the Founder and the Managing Member of The Angels’ Forum and The Halo Funds. She has 30 years of experience with investing, entrepreneurial, and large corporate institutions. Carol’s career started in the Midwest where she was a bank officer with First Bank Systems and held marketing and sales positions with Motorola and Xerox Computer Services. After moving to San Francisco, she was hired into executive positions at Arthur Young (Ernst & Young) and Coopers & Lybrand (PricewaterhouseCoopers). In 1997, she formed The Angels’ Forum, an innovative angel group. The Angels’ Forum organizes individual investors with previous entrepreneurial experience to invest using a venture capital model for due diligence, mentoring, and board management. In 1997, she formed The Angels’ Forum, an innovative angel group. The Angels’ Forum organizes individual investors with previous entrepreneurial experience to invest using a venture capital model for due diligence, mentoring, and board management. A globally recognized expert, Carol consults with government officials and corporations about early-stage investing and innovation. She teaches “Angel Investing for the Serious Investor†at Stanford University’s Continuing Education Program and has guest lectured at other universities around the world. An active investor, she belongs to or consults with many organizations that support the entrepreneurial spirit including The Indus Entrepreneurs (TiE) as a Charter Member, SV Forum, M31, CINA, The Band of Angels, Golden Seeds, Berkeley and The Stanford Angels & Entrepreneurs. Involved in women’s leadership, she is on the Advisory Board for Global Women’s Leadership Network and is a member of The International Women’s Forum. Passionate about the impact that small amounts of money can make when combined with innovative thinking, she is also a Director of the Sands Family Foundation which funds early stage and pre NIH (National Institute of Health) research relating to prostate and ovarian cancers. Carol received her B.A. in Business Administration from The University of Iowa.
Follow Carol Sands:
About The Angels’ Forum, The Halo Fund, TVLP Institute Silicon Valley: The Angels’ Forum is a hybrid venture/angel firm that invests in Software, Technology, and Life Sciences.
Andrew McMurry
Chief Technology Officer, Co-Founder of Medal
Follow Andrew McMurry:
About Medal: Extract, transport, translate, and share medical records faster.
Aldo Carrascoso
Co-Founder and CEO of InterVenn
Aldo is the Co-Founder and Chief Executive Officer of InterVenn Biosciences. InterVenn combines next-generation glycomics (carbohydrates), instrumentation (LC/MS), and deep machine learning to augment cancer diagnosis, biomarker, and target discovery for the development of more efficacious molecular diagnostics. Venn was founded by a team of serial entrepreneurs with repeated and proven track record of success (value creation of half a billion dollars) and execution in the fields of Machine Learning, Analytical Chemistry through Liquid Chromatography / Mass Spectrometry and in Oncological Glycoproteomics. Prior to Venn, Aldo was the Founder and COO / CTO of San Francisco based Veem (formerly Align Commerce), a next generation replacement for outdated wire and telegraphic transfer systems. Align uses the blockchain and its proprietary multi-rail systems to change the way global cross border payments are done – making the process simpler, faster and more transparent to over 60 countries. Some of the company’s investors include Kleiner, Perkins, Caufield, Byers (the same venture capital responsible for Google, Twitter, Amazon, Uber, Waze, Slack, and Snapchat among others), Google Ventures, Softbank Ventures, National Australian Bank, Silicon Valley Bank Ventures, Recruit Strategic Partners, and NYCA Investment Partnership LP (led by Hans Morris, former President of Visa and Max Levchin, founding CTO of PayPal). Prior to founding Veem, Aldo was the Founder and CTO of Jukin Technologies / Jukin Media – one of the world’s largest User Generated Content (UGC) payments and licensing platforms with over 60 billion global views, 50 million platform shares and over 10 million active contributors and subscribers in 221 markets. Jukin is currently being used by some of the world’s largest television networks and production companies including ABC, BBC, CBS, Comedy Central, CNN, Discovery, ESPN, FOX, HBO, MTV, NBC, TruTV, Vh1, and hundreds of other websites, and platforms throughout the world. Jukin’s main properties include FailArmy, JukinVideo, People Are Awesome, The Pet Collective, World’s Funniest on FOX and That are Funny! on UK’s Channel 5. Samsung Investments, Bertelsmann Digital Media Investments Inc., Launchpad LA, and Maker Studios are some of Jukin’s lead investors. Aldo is a serial entrepreneur, angel investor, and technology disruptor. Prior to Jukin, he founded a number of ventures in global B2B matchmaking, international trading/finance, and business process outsourcing. Aldo has an MBA in Entrepreneurship from Babson and a degree in Psychology from Ateneo De Manila University.
Follow Aldo Carrascoso:
About InterVenn, Jukin Media, Jukinvideo, Veem: InterVenn Biosciences identifies, quantifies, and classifies Glycoproteomic and other PTM signals found in human blood and tissue.
Ammar Khan
Co-Founder & CTO of Medsender
CTO @ Medsender
Follow Ammar Khan:
About Medsender: Modernizing healthcare communication and automating care coordination workflows
Joy Sun
Co-Founder of Groups Recover Together
Follow Joy Sun:
About Groups Recover Together, MAPS Public Benefit, Corp.: Groups Recover Together provides accessible and affordable medication-assisted treatment (MAT) for opioid addiction.
Daren Joy
Founder of Lifefactory
As an award-winning integrative designer and architect, Daren has an innate sense of aesthetic, proportion and style that is both cutting-edge and familiar. Daren begins his designs by deciphering how objects and environments affect one’s overall well-being, allowing his work to appeal to a wide range of physical and emotional senses. Daren’s designs won Metropolitan Home Magazine’s Home of the Year contests in 1996 and 2005. As a father of three, Daren has grown even more committed to the environment and a holistic view of health. With that in mind, he joined Pam and brings his passion for life and design to Lifefactory.
Follow Daren Joy:
About Lifefactory: Lifefactory produces BPA-free glass bottles, baby bottles, water bottles, teethers, glass bottles with silicone sleeves, and teethers.
Shaun Rahimi
Founder and CEO of ENSO
Shaun Rahimi is CEO and founder of Thimble Bioelectronics. An award-winning innovator that has worked on the design and development of over 40 different medical devices at start ups since he was 15 years old. He has also held R&D roles at Neuropace, Sadra Medical, Modified Polymer Components and Abbott Labs where he participated in the design and development of novel polymer-based products and manufacturing processes.
Follow Shaun Rahimi:
About ENSO, Innovation Quest: ENSO is a wearable device shown in clinical trials to solve pain better than Vicodin
Glen McLaughlin
President, Founder,CTO of Zonare Medical Systems
Follow Glen McLaughlin:
About Zonare Medical Systems: Zonare Medical Systems develops compact ultrasound systems that are used for diagnostic imaging activities in clinical applications.
Willam Rutter
CEO and Founder of Boston Biomedical
Dr. Rutter is Chairman and Founder of Synergenics, LLC, which owns and controls a portfolio of biotechnology companies at various stages of development. In his academic career, Dr. Rutter joined the University of California–San Francisco (UCSF) as head of the newly formed department of Biochemistry and Biophysics in 1968, and played a key role in developing UCSF into a major scientific institution. In research, he is particularly known for the discovery of the enzymes involved in the expression of DNA (RNA polymerases), the first cloning of the insulin gene, the cloning of hepatitis B virus (HBV), and formation of an HBV-like particle that provided the basis for a safe and protective vaccine. With 2 colleagues, Dr. Rutter founded Chiron in 1981, a pioneering biotech firm that developed the first recombinant vaccine (against HBV) with Merck and a process for manufacturing insulin from yeast with Novo-Nordisk. Chiron was the first to clone the AIDS (HIV) virus and to discover, clone, and sequence the hepatitis C virus (HCV). Chiron developed quantitative diagnostic tests for HIV, HBV, and HCV, thus providing the means for eliminating blood contaminated with these viruses, a major contribution to public health worldwide. Chiron developed and promulgated the concept of “viral load” as the basis for determining disease status, as well as the basis for developing and evaluating antivirals and other treatment protocols for these and other diseases. Prior to Chiron, Dr. Rutter was a consultant to Abbott Laboratories for about 20 years, and a member of the Amgen Scientific Advisory Board. Dr. Rutter’s past board memberships include Novartis, Sangamo Biosciences, Cytokinetics, Nugen, Oscient Pharmaceuticals, and Epitomics. Dr. Rutter also currently serves on the boards of Eureka Genomics, Apexigen, One Globe, and Cellworks. He is Chairman of the Synergenics companies: Synco Biopartners, ReLIA Diagnostic Systems, Numera Health, Ventria Bioscience, Humabs Biomed, Pathologica, and BioEnergenix. Dr. Rutter is a member of the National Academy of Sciences and the American Academy of Arts and Sciences, and has received numerous awards for his contributions to science and the biotechnology industry.
Follow Willam Rutter:
About Boston Biomedical: Boston Biomedical focuses on the research and development of novel therapeutics to treat cancer.
James Sinka
Co-Founder and CEO of SleepWell.ai
James Sinka is the Co-Founder and CEO of SleepWell.ai. He tested the best science-backed sleep remedies and discovered what’s best using sleep trackers. Mr. Sinka uses his experiences from his lifelong study of biology and chemistry to bring you tried and true results.
Follow James Sinka:
About Hypnos, SleepWell.ai: SleepWell.ai is a technology platform that resolves your sleep issues with research backed science.
Anthony Ortiz
Founder & CEO of Fitly
Anthony Ortiz, Founder and CEO at Fitly. Fitly is the creator of SmartPlate, is a two-time Digital Health award winner, University City Science Center-backed and DreamIt Health alumni, with a proven track record for vetted, technological innovation. SmartPlate is the world’s first intelligent plate that instantly tracks and analyzes everything you eat, so you never have to track meals manually again.
Follow Anthony Ortiz:
About Fitly: Fitly is the creator of SmartPlate, the world’s only intelligent nutrition platform.
Jared Seehafer
Co-Founder & CEO of Enzyme
Jared is an 11 year veteran of the medical device and biopharma industries, with a background in product management, medical device software, design assurance and regulatory strategy. His experience ranges from leading spinal cord stimulator programs at St. Jude Neuromodulation (now Abbott), to the UI/UX for the first hybrid closed loop insulin pump at Medtronic Diabetes, to the regulatory strategy for numerous combination drug-device products, including Amgen’s Neulasta Onpro and Repatha Pushtronex. Prior to his experience in the life sciences he trained and worked as a software engineer. He holds a BA from the University of Colorado and an MS in Medical Device Engineering from USC.
Follow Jared Seehafer:
About Enzyme, Village Global: Enzyme is building software to help life sciences companies with FDA approval and regulatory compliance.
Jacob Graham
Co-Founder & VP QA/RA of Enzyme
Jacob is an 11 year veteran of the medical device industry, with a background in quality management, design assurance, and audit planning. He has helped commercially launch several Class II and III devices and has overseen multiple FDA and EU notified body audits. Prior to co-founding Enzyme he held quality management positions at Medtronic and Boston Scientific. Jacob has an MBA from Babson College and a BS in Engineering from Olin College. Additionally he has achieved several professional certifications in the life sciences, and is an ASQ Certified Biomedical Auditor and RAPS Regulatory Affairs Certified (US).
Follow Jacob Graham:
About Enzyme: Enzyme is building software to help life sciences companies with FDA approval and regulatory compliance.
Wei Deng
CEO & Founder of Clipboard Health
CEO & Founder of Clipboard Health .
Follow Wei Deng:
About Clipboard Health: Clipboard Health is a marketplace where nurses and CNAs can search for jobs, and where healthcare facilities can fill open shifts.
Atul Butte
Co-Founder & Scientific Advisor of NuMedii
Atul Butte, MD, PhD is the Priscilla Chan and Mark Zuckerberg Distinguished Professor and inaugural Director of the Bakar Computational Health Sciences Institute (bchsi.ucsf.edu) at the University of California, San Francisco (UCSF). Dr. Butte is also the Chief Data Scientist for the entire University of California Health System, the tenth largest by revenue in the United States, with 20 health professional schools, 6 medical schools, 6 academic health centers, 10 hospitals, and over 1000 care delivery sites. Dr. Butte has been continually funded by NIH for 20 years, is an inventor on 24 patents, and has authored over 200 publications, with research repeatedly featured in the New York Times, Wall Street Journal, and Wired Magazine. Dr. Butte was elected into the National Academy of Medicine in 2015, and in 2013, he was recognized by the Obama Administration as a White House Champion of Change in Open Science for promoting science through publicly available data. Dr. Butte is also a founder of three investor-backed data-driven companies: Personalis (IPO, 2019), providing medical genome sequencing services, Carmenta (acquired by Progenity, 2015), discovering diagnostics for pregnancy complications, and NuMedii, finding new uses for drugs through open molecular data. Dr. Butte trained in Computer Science at Brown University, worked as a software engineer at Apple and Microsoft, received his MD at Brown University, trained in Pediatrics and Pediatric Endocrinology at Children’s Hospital Boston, then received his PhD from Harvard Medical School and MIT.
Follow Atul Butte:
About NuMedii, Personalis, University of California, San Francisco: NuMedii is a biotechnology company that discovers and de-risks effective drugs by translating life sciences big data into therapies.
Zheng Yang
Co-Founder of Mira
Zheng Yang is a co-founder of Quanovate, the company behind Mira.
Follow Zheng Yang:
About Mira, Quanovate: The first FDA and CE registered comprehensive women’s health and chronic disease monitoring platform with 99% of accuracy
Rajatesh Gudibande
Co-Founder & President of GraphWear Technologies
Rajatesh Gudibande is the Co-Founder and President at GraphWear Technologies.
Follow Rajatesh Gudibande:
About GraphWear Technologies: The world’s first needle free continuous health monitoring platform
Brook Ayalneh
Co-Founder & CEO of Avion
Brook Ayalneh is the CEO and founder of Avion.
Follow Brook Ayalneh:
About Avion: Avion is an autonomous aerial network that delivers medicals and vaccine supplies via drones.
Bo Hu
Co-Founder and CTO of MORE Health
Former senior software engineer in Sina. M.S. University of San Francisco and B.S. University of Science and Technology of China.
Follow Bo Hu:
About MORE Health: MORE Health delivers access to the best physicians in the world via its cloud-based medical collaboration platform.
Camilla Hermann
Co-Founder & CEO of Oath Care
Follow Camilla Hermann:
About Oath Care: Oath Care is building a new model of group-based, continuous care to meaningfully improve health outcomes for the next generation of kids.
Steve Budill
Co-Founder of BH2 Innovations
Steve Budill currently works as the Co-founder for BH2 Innovations. He previously worked at SteriView, Inc. as the Vice President.
Follow Steve Budill:
About BH2 Innovations: BH2 Innovations is a product development firm that specializes in technologies that address unmet needs in the healthcare industry.
Ravi Shah
Founder & Head of Product of Marigold Health
Follow Ravi Shah:
About Marigold Health: Marigold Health uses chat support groups to make substance use treatment more engaging and personalized for vulnerable populations.
Dore Mark
Co-Founder, Technology of Microtech Medical
Dore Mark is the Co-Founder, Technology at MicroTech Medical.
Follow Dore Mark:
About Microtech Medical: Microtech Medical is a Chinese medical equipment start-up developing and manufacturing medical devices.
Victor McCray
Founder & CEO of Tangible Science
Vic McCray, MD is a Co-Founder of Tangible Science and serves as its President and Chief Executive Officer, where he leads commercialization of technology to improve contact lens comfort for patients suffering from dry eye disease. Involved at the inception, Vic has seen the company through several important milestones including initial proof of concept, venture funding, and the ongoing business development and licensing negotiations.
Follow Victor McCray:
About Santa Clara Valley Medical Center, Stanford Byers Center for Biodesign, Tangible Science: Tangible Science is a developer of contact lenses designed to reduce lens discomfort in dry eye diseases.
Yoitsu Kamijo
Co-Founder of Pine Park Health
Yoitsu Kamijo is the Co-Founder at Pine Park Health.
Follow Yoitsu Kamijo:
About Pine Park Health, Pine Park Health: Pine Park Health works with medicare advantage plans, senior living communities, and providers to improve health outcomes for seniors.
Orestis Vardoulis
Co-Founder & CEO of Zeit Medical
Orestis Vardoulis currently works as the Co-Founder and CEO for ZeitMedical.
Follow Orestis Vardoulis:
About Zeit Medical: Zeit Medical provides peace of mind to neurology injury patients through powered AI and cutting edge Bioelectronics.
H. Lee Mosbacker
Founder & CTO of Traycer Diagnostic Systems
H. Lee Mosbacker joined CAPRICA AI as CEO in 2018. Dr. Mosbacker received his B.S. in physics from Ohio University’s Honors Tutorial College in 1999. From 2000 – 2002 he worked as a programmer analyst at Nationwide Financial developing market timing applications for mutual fund managers. In 2008, Lee received his PhD in Physics from The Ohio State University. Since 2007, Lee has been the Chief Technology Officer of Traycer Diagnostic Systems, where he has been involved in the scientific and technical aspects of growing an early-stage technology company, including grant and fund raising and the conceptualization and development of microwave and terahertz frequency detection arrays. In 2005, Lee co-founded Techriculture, a non-profit that helps inventors and scientists in early stage product ideation and prototype development through educational, networking, technical, and financial consulting.
Follow H. Lee Mosbacker:
About CAPRICA AI, HackCancerSF, OcuDoc, Syndicate app, Traycer Diagnostic Systems: Traycer Diagnostic Systems develops terahertz radiation cameras that are integrated into imaging systems.
David Guaraglia
Co-Founder of Virgo Surgical Video Solutions
Follow David Guaraglia:
About Virgo Surgical Video Solutions: Virgo accelerates clinical trials with AI for endoscopy
Akash Bakshi
CEO and Co-Founder of ANA Therapeutics
Akash Bakshi is the Co-Founder and CEO of ANA Therapeutics.
Follow Akash Bakshi:
About ANA Therapeutics, NeuroBo Pharmaceuticals, YourChoice Therapeutics: ANA Therapeutics is a biotech company that is developing a novel coronavirus vaccine intended to save human lives.
Andrew Bartynski
Co-Founder and COO of ANA Therapeutics
Andrew Bartynski is the Co-Founder and COO of ANA Therapeutics.
Follow Andrew Bartynski:
About AesculaTech, ANA Therapeutics: ANA Therapeutics is a biotech company that is developing a novel coronavirus vaccine intended to save human lives.
